FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely ophthalmology, and can be used in the treatment of post-concussion optical neuropathy. To do this, a course of treatment is carried out for 10 days: intravenously once a day citicoline 1.0 ml, intramuscularly once a day dicinone 1.0 ml. Dexazone 0.5 ml is administered parabolically once a day. Starting from the first day of treatment, 10 sessions of physiotherapy are performed, including daily use of magnetic therapy sequentially into two projection zones of the visual analyzer: the eyeball and temporal regions, in reverse mode, the reverse time is 10 seconds, with a frequency of 50 Hz for 10 minutes, as well as 10 sessions, one session per day, nasal electrophoresis through the nose with turunds impregnated with 0.1% semax, from the positive pole for 10 minutes. The drugs are administered in a row in the specified sequence, the interval between the administration of all drugs and physiotherapy procedures - electrophoresis and magnetic therapy - is 30 minutes, while magnetic therapy is performed first, and electrophoresis after 10 minutes.
EFFECT: invention provides an increase in visual functions in this category of patients, which in turn allows them to quickly restore their ability to work and improve their quality of life.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
METHOD FOR THE TREATMENT OF ACUTE OPTIC NEUROPATHY IN DRUSEN OF THE OPTIC NERVE HEAD | 2022 |
|
RU2794569C1 |
METHOD FOR TREATING ANTERIOR ISCHEMIC OPTIC NEUROPATHY WITH OPTIC DISC DRUSEN | 2023 |
|
RU2807392C1 |
METHOD FOR TREATING ACUTE VASCULAR OPTIC NEUROPATHY | 2005 |
|
RU2281071C1 |
METHOD FOR TREATMENT OF OPTIC NERVE ATROPHY WITH OPTIC DISC DRUSEN | 2022 |
|
RU2788811C1 |
METHOD OF TREATING PATIENTS WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY | 2011 |
|
RU2480252C1 |
METHOD OF TREATING OPTIC NEUROPATHY AFTER CRANIOCEREBRAL INJURY IN REMOTE PERIOD | 2009 |
|
RU2398553C1 |
METHOD OF THE TREATMENT OF OPTIC NERVE ATROPHY IN THE POST-COVID PERIOD | 2022 |
|
RU2801486C1 |
METHOD OF TREATING TOXIC OPTIC NEUROPATHY, INDUCED BY LONG INTAKE OF CODEINE-CONTAINING MEDICATIONS | 2010 |
|
RU2424796C1 |
METHOD OF TREATING LUETIC OPTIC NEUROPATHY | 2012 |
|
RU2494775C1 |
Authors
Dates
2024-09-04—Published
2024-01-31—Filed